-
1
-
-
0003964363
-
-
American Cancer Society. Atlanta: American Cancer Society
-
American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014.
-
(2014)
Cancer Facts & Figures 2014
-
-
-
3
-
-
81555220918
-
Pathobiology and chemoprevention of bladder cancer
-
Tanaka T, Miyazawa K, Tsukamoto T, Kuno T, Suzuki K. Pathobiology and chemoprevention of bladder cancer. J Oncol 2011;2011: 1-23.
-
(2011)
J Oncol
, vol.2011
, pp. 1-23
-
-
Tanaka, T.1
Miyazawa, K.2
Tsukamoto, T.3
Kuno, T.4
Suzuki, K.5
-
4
-
-
77950346282
-
Immunity, inflammation, and cancer
-
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
-
(2010)
Cell
, vol.140
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
5
-
-
34247638102
-
Chronic inflammation and bladder cancer
-
DOI 10.1016/j.urolonc.2006.10.002, PII S107814390600233X, Inflammation in Bladder and Prostate Carcinogenesis
-
Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007;25:260-8. (Pubitemid 46670749)
-
(2007)
Urologic Oncology: Seminars and Original Investigations
, vol.25
, Issue.3
, pp. 260-268
-
-
Michaud, D.S.1
-
6
-
-
0043239039
-
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder
-
DOI 10.1097/01.ju.0000080401.85145.ee
-
Shariat SF, Matsumoto K, Kim J, Ayala GE, Zhou JH, Jian W, et al. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol 2003;170:985-9. (Pubitemid 36999617)
-
(2003)
Journal of Urology
, vol.170
, Issue.3
, pp. 985-989
-
-
Shariat, S.F.1
Matsumoto, K.2
Kim, J.3
Ayala, G.E.4
Zhou, J.-H.5
Jian, W.6
Benedict, W.F.7
Lerner, S.P.8
-
7
-
-
0141988847
-
Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors
-
DOI 10.1097/01.ju.0000080296.54262.c8
-
Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 2003;170:1994-9. (Pubitemid 37254995)
-
(2003)
Journal of Urology
, vol.170
, Issue.5
, pp. 1994-1999
-
-
Yoshimura, R.1
Matsuyama, M.2
Tsuchida, K.3
Kawahito, Y.4
Sano, H.5
Nakatani, T.6
-
8
-
-
67549122884
-
Levels of prostaglandin E metabolite and leukotriene E4 are increased in the urine of smokers: Evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway
-
Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, et al. Levels of prostaglandin E metabolite and leukotriene E4 are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res 2009;2:322-9.
-
(2009)
Cancer Prev Res
, vol.2
, pp. 322-329
-
-
Duffield-Lillico, A.J.1
Boyle, J.O.2
Zhou, X.K.3
Ghosh, A.4
Butala, G.S.5
Subbaramaiah, K.6
-
9
-
-
34249065795
-
Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines
-
Schroeder CP, Yang P, Newman RA, Lotan R. Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines. J Exp Ther Oncol 2007;6:183-92. (Pubitemid 46789718)
-
(2007)
Journal of Experimental Therapeutics and Oncology
, vol.6
, Issue.3
, pp. 183-192
-
-
Schroeder, C.P.1
Yang, P.2
Newman, R.A.3
Lotan, R.4
-
10
-
-
47849093031
-
Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2
-
Zhang Bo, Chang-Liang Wang, Wen-Hua Zhao, Ming Lv, Chun-Ying Wang, Wei-Xia Zhong, et al. Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2. World J Gastroenterol 2008;14:2494-500
-
(2008)
World J Gastroenterol
, vol.14
, pp. 2494-2500
-
-
Bo, Z.1
Wang, C.-L.2
Zhao, W.-H.3
Lv, M.4
Wang, C.-Y.5
Zhong, W.-X.6
-
11
-
-
0035584272
-
Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
-
DOI 10.1016/S0006-2952(01)00747-X, PII S000629520100747X
-
Fiorucci S, Meli R, Bucci M, Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 2001;62:1433-8. (Pubitemid 33145286)
-
(2001)
Biochemical Pharmacology
, vol.62
, Issue.11
, pp. 1433-1438
-
-
Fiorucci, S.1
Meli, R.2
Bucci, M.3
Cirino, G.4
-
12
-
-
0038328335
-
First clinical results of licofelone (ML3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis
-
Reginster JY, Bias P, Buchner A. First clinical results of licofelone (ML3000), an inhibitor of COX-1, COX-2 and 5-LOX, for the treatment of osteoarthritis. Ann Rheum Dis 2002;61:116-7.
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 116-117
-
-
Reginster, J.Y.1
Bias, P.2
Buchner, A.3
-
13
-
-
1242342177
-
Licofelone - Clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis
-
Alvaro-Gracia JM. Licofelone-clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis. Rheumatology (Oxford) 2004;43 Suppl 1:i21-5. (Pubitemid 38219704)
-
(2004)
Rheumatology
, vol.43
, Issue.SUPPL. 1
-
-
Alvaro-Gracia, J.M.1
-
14
-
-
80051521413
-
Chemoprevention of colon carcinogenesis by licofelone, a novel dual 5-LOX/COX inhibitor, in F344 rats
-
[abstract]. Los Angeles, CA: AACR; Abstract nr 11
-
Rao CV, Swamy MV, Choi C, Janakiram NB, Patlolla JM, Steele VE. Chemoprevention of colon carcinogenesis by licofelone, a novel dual 5-LOX/COX inhibitor, in F344 rats [abstract]. In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; 2007; Los Angeles, CA: AACR; 2007. Vol. 48. Abstract nr 11.
-
(2007)
Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; 2007
, vol.48
-
-
Rao, C.V.1
Swamy, M.V.2
Choi, C.3
Janakiram, N.B.4
Patlolla, J.M.5
Steele, V.E.6
-
15
-
-
83055195235
-
Chemoprevention of colon and small intestinal tumorigenesis in APCMin/+ Mice by licofelone, a novel dual 5-LOX/COX inhibitor: Potential implications for human colon cancer prevention
-
Mohammed A, Janakiram NB, Li Q, Choi C-I, Zhang Y, Steele VE, et al. Chemoprevention of colon and small intestinal tumorigenesis in APCMin/+ Mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prev Res 2011;4:2015-26.
-
(2011)
Cancer Prev Res
, vol.4
, pp. 2015-2026
-
-
Mohammed, A.1
Janakiram, N.B.2
Li, Q.3
Choi, C.-I.4
Zhang, Y.5
Steele, V.E.6
-
16
-
-
80051489648
-
Chemopreventive efficacy and mechanism of licofelone in a mouse lung tumor model via aspiration
-
Sharma S, Lee J, Zhou J, Steele VE. Chemopreventive efficacy and mechanism of licofelone in a mouse lung tumor model via aspiration. Cancer Prev Res 2011;4:1233-42.
-
(2011)
Cancer Prev Res
, vol.4
, pp. 1233-1242
-
-
Sharma, S.1
Lee, J.2
Zhou, J.3
Steele, V.E.4
-
17
-
-
34547736054
-
Anticancer effects of licofelone (ML-3000) in prostate cancer cells
-
Narayanan NK, Nargi D, Attur M, Abramson SB, Narayanan BA. Anticancer effects of licofelone (ML-3000) in prostate cancer cells. Anticancer Res 2007;27:2393-402. (Pubitemid 47228080)
-
(2007)
Anticancer Research
, vol.27
, Issue.4 B
, pp. 2393-2402
-
-
Narayanan, N.K.1
Nargi, D.2
Attur, M.3
Abramson, S.B.4
Narayanan, B.A.5
-
18
-
-
0033565558
-
Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma
-
Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 1999;59:3512-7. (Pubitemid 29334516)
-
(1999)
Cancer Research
, vol.59
, Issue.14
, pp. 3512-3517
-
-
Zhang, Z.-T.1
Pak, J.2
Shapiro, E.3
Sun, T.-T.4
Wu, X.-R.5
-
20
-
-
84876561056
-
Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor
-
Hsu J-W, Hsu I, Xu D, Miyamoto H, Liang L, Wu X-R, et al. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Am J Pathol 2013;182:1811-20.
-
(2013)
Am J Pathol
, vol.182
, pp. 1811-1820
-
-
Hsu, J.-W.1
Hsu, I.2
Xu, D.3
Miyamoto, H.4
Liang, L.5
Wu, X.-R.6
-
21
-
-
84890522483
-
Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model
-
Liu Z, Xu X, Li X, Liu S, Simoneau AR, He F, et al. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res 2013;6:1365-75.
-
(2013)
Cancer Prev Res
, vol.6
, pp. 1365-1375
-
-
Liu, Z.1
Xu, X.2
Li, X.3
Liu, S.4
Simoneau, A.R.5
He, F.6
-
22
-
-
84881077064
-
p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice
-
Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, et al. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia 2013;15:966-74.
-
(2013)
Neoplasia
, vol.15
, pp. 966-974
-
-
Madka, V.1
Zhang, Y.2
Li, Q.3
Mohammed, A.4
Sindhwani, P.5
Lightfoot, S.6
-
23
-
-
0035710746
-
-ΔΔCT method
-
DOI 10.1006/meth.2001.1262
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-8. (Pubitemid 34164012)
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
24
-
-
84904364275
-
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer
-
Zhu Z, Shen Z, Xu C. Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm 2012;1-11.
-
(2012)
Mediators Inflamm
, pp. 1-11
-
-
Zhu, Z.1
Shen, Z.2
Xu, C.3
-
25
-
-
33746405729
-
Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells
-
DOI 10.1111/j.1442-2042.2006.01485.x
-
Hayashi T, Nishiyama K, Shirahama T. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells. Int J Urol 2006;13:1086-91. (Pubitemid 44125681)
-
(2006)
International Journal of Urology
, vol.13
, Issue.8
, pp. 1086-1091
-
-
Hayashi, T.1
Nishiyama, K.2
Shirahama, T.3
-
26
-
-
4444225108
-
Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma
-
DOI 10.1016/j.colsurfb.2004.05.011, PII S0927776504001420
-
Li G, Yang T, Li L, Yan J, Zeng Y, Yu J, et al. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. Colloids Surfaces B Biointerfaces 2004;37:15-9. (Pubitemid 39164189)
-
(2004)
Colloids and Surfaces B: Biointerfaces
, vol.37
, Issue.1-2
, pp. 15-19
-
-
Li, G.1
Yang, T.2
Li, L.3
Yan, J.4
Zeng, Y.5
Yu, J.6
Zhang, Y.7
-
27
-
-
0032528189
-
Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl) nitrosamine
-
Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, et al. Chemo- preventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the develop- ment of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res 1998;58:3028-31. (Pubitemid 28335083)
-
(1998)
Cancer Research
, vol.58
, Issue.14
, pp. 3028-3031
-
-
Okajima, E.1
Denda, A.2
Ozono, S.3
Takahama, M.4
Akai, H.5
Sasaki, Y.6
Kitayama, W.7
Wakabayashi, K.8
Konishi, Y.9
-
28
-
-
24144484811
-
Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder
-
DOI 10.1007/s11255-004-4699-z
-
Wadhwa P, Goswami AK, Joshi K, Sharma SK: Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol 2005;37:47-53. (Pubitemid 41236242)
-
(2005)
International Urology and Nephrology
, vol.37
, Issue.1
, pp. 47-53
-
-
Wadhwa, P.1
Goswami, A.K.2
Joshi, K.3
Sharma, S.K.4
-
29
-
-
0034667354
-
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
-
Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, et al. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 2000;60:5599-602.
-
(2000)
Cancer Res
, vol.60
, pp. 5599-5602
-
-
Grubbs, C.J.1
Lubet, R.A.2
Koki, A.T.3
Leahy, K.M.4
Masferrer, J.L.5
Steele, V.E.6
-
30
-
-
0027144039
-
Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model
-
DOI 10.1002/ijc.2910550622
-
Shibata MA, Hasegawa R, Shirai T, Takesada Y, Fukushima S. Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Int J Cancer 1993;55: 1011-7. (Pubitemid 24005349)
-
(1993)
International Journal of Cancer
, vol.55
, Issue.6
, pp. 1011-1017
-
-
Shibata, M.-A.1
Hasegawa, R.2
Shirai, T.3
Takesada, Y.4
Fukushima, S.5
-
31
-
-
0031059193
-
Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma
-
Cook GP, Hampton JA. Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma. Anticancer Res 1997;17:365-8. (Pubitemid 27116693)
-
(1997)
Anticancer Research
, vol.17
, Issue.1 A
, pp. 365-368
-
-
Cook, G.P.1
Hampton, J.A.2
-
32
-
-
80053918672
-
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer
-
Sabichi AL, Lee JJ, Grossman HB, Liu S, Richmond E, Czerniak BA, et al. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res 2011;4:1580-9.
-
(2011)
Cancer Prev Res
, vol.4
, pp. 1580-1589
-
-
Sabichi, A.L.1
Lee, J.J.2
Grossman, H.B.3
Liu, S.4
Richmond, E.5
Czerniak, B.A.6
-
33
-
-
44049101630
-
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-1
-
Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, et al. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol 2008;8:7.
-
(2008)
BMC Urol
, vol.8
, pp. 7
-
-
Johnson, A.M.1
O'Connell, M.J.2
Miyamoto, H.3
Huang, J.4
Yao, J.L.5
Messing, E.M.6
-
34
-
-
58849089319
-
Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes
-
Wang X, Colby JKL, Rengel RC, Fischer SM, Clinton SK, Klein RD. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes. Mol Carcinog 2009;48:1-13.
-
(2009)
Mol Carcinog
, vol.48
, pp. 1-13
-
-
Wang, X.1
Colby, J.K.L.2
Rengel, R.C.3
Fischer, S.M.4
Clinton, S.K.5
Klein, R.D.6
-
35
-
-
40549108939
-
Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade
-
DOI 10.1093/carcin/bgm265
-
Tavolari S, Bonafe M, Marini M, Ferreri C, Bartolini G, Brighenti E, et al. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 2008;29:371-80. (Pubitemid 351359677)
-
(2008)
Carcinogenesis
, vol.29
, Issue.2
, pp. 371-380
-
-
Tavolari, S.1
Bonafe, M.2
Marini, M.3
Ferreri, C.4
Bartolini, G.5
Brighenti, E.6
Manara, S.7
Tomasi, V.8
Laufer, S.9
Guarnieri, T.10
-
36
-
-
84877070255
-
Multitargeted low-dose GLAD combination chemoprevention: A novel and promising approach to combat colon carcinogenesis
-
Mohammed A, Janakiram NB, Brewer M, Vedala K, Steele VE, Rao CV. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Neoplasia (Internet) 2013;15:481-90.
-
(2013)
Neoplasia (Internet)
, vol.15
, pp. 481-490
-
-
Mohammed, A.1
Janakiram, N.B.2
Brewer, M.3
Vedala, K.4
Steele, V.E.5
Rao, C.V.6
-
37
-
-
0038679686
-
Cyclin E overexpression and amplification in human tumours
-
DOI 10.1002/path.1356
-
Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, et al. Cyclin E overexpression and amplification in human tumours. J Pathol 2003;200:375-82. (Pubitemid 36827312)
-
(2003)
Journal of Pathology
, vol.200
, Issue.3
, pp. 375-382
-
-
Schraml, P.1
Bucher, C.2
Bissig, H.3
Nocito, A.4
Haas, P.5
Wilber, K.6
Seelig, S.7
Kononen, J.8
Mihatsch, M.J.9
Dirnhofer, S.10
Sauter, G.11
-
38
-
-
28844461573
-
ARF methylation as a potential biomarker for human bladder cancer
-
DOI 10.1016/j.bbrc.2005.11.072, PII S0006291X05025799
-
Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, et al. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Biochem Biophys Res Commun 2006; 339:790-6. (Pubitemid 41772883)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.339
, Issue.3
, pp. 790-796
-
-
Kawamoto, K.1
Enokida, H.2
Gotanda, T.3
Kubo, H.4
Nishiyama, K.5
Kawahara, M.6
Nakagawa, M.7
-
39
-
-
0028853608
-
Deletion of the p16 and p15 genes in human bladder tumors
-
Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, et al. Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst 1995;87:1524-9.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1524-1529
-
-
Orlow, I.1
Lacombe, L.2
Hannon, G.J.3
Serrano, M.4
Pellicer, I.5
Dalbagni, G.6
-
40
-
-
0141816863
-
Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53
-
Swamy MV, Herzog CR, Rao CV. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Res 2003;63:5239-42. (Pubitemid 37139836)
-
(2003)
Cancer Research
, vol.63
, Issue.17
, pp. 5239-5242
-
-
Swamy, M.V.1
Herzog, C.R.2
Rao, C.V.3
-
41
-
-
84896115135
-
Anti-tumor activity of nonsteroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
-
Liggett JL, Zhang X, Eling TE, Baek SJ. Anti-tumor activity of nonsteroidal anti-inflammatory drugs: cyclooxygenase-independent targets. Cancer Lett 2014;346:217-24.
-
(2014)
Cancer Lett
, vol.346
, pp. 217-224
-
-
Liggett, J.L.1
Zhang, X.2
Eling, T.E.3
Baek, S.J.4
-
42
-
-
67649969215
-
Expression analysis of VEGF-A and VEGF-B: Relationship with clinicopathological parameters in bladder cancer
-
Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, et al. Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer. Oncol Rep 2009;21:1495-504.
-
(2009)
Oncol Rep
, vol.21
, pp. 1495-1504
-
-
Fauconnet, S.1
Bernardini, S.2
Lascombe, I.3
Boiteux, G.4
Clairotte, A.5
Monnien, F.6
-
43
-
-
84881348980
-
Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer
-
Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, et al. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res 2013;33:2381-90.
-
(2013)
Anticancer Res
, vol.33
, pp. 2381-2390
-
-
Kopparapu, P.K.1
Boorjian, S.A.2
Robinson, B.D.3
Downes, M.4
Gudas, L.J.5
Mongan, N.P.6
-
44
-
-
30744476528
-
Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells
-
DOI 10.1016/j.cardiores.2005.09.019, PII S0008636305004931
-
Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 2006;69:512-9. (Pubitemid 43098807)
-
(2006)
Cardiovascular Research
, vol.69
, Issue.2
, pp. 512-519
-
-
Wu, G.1
Luo, J.2
Rana, J.S.3
Laham, R.4
Sellke, F.W.5
Li, J.6
-
45
-
-
0142074916
-
COX-2/VEGF-Dependent Facilitation of Tumor-Associated Angiogenesis and Tumor Growth In Vivo
-
DOI 10.1097/01.LAB.0000090159.53224.B9
-
Yoshida S, Amano H, Hayashi I, Kitasato H, Kamata M, Inukai M, et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003;83:1385-94. (Pubitemid 37267822)
-
(2003)
Laboratory Investigation
, vol.83
, Issue.10
, pp. 1385-1394
-
-
Yoshida, S.1
Amano, H.2
Hayashi, I.3
Kitasato, H.4
Kamata, M.5
Inukai, M.6
Yoshimura, H.7
Majima, M.8
|